1. Home
  2. List
Reference Patent

Reference - List

  • 35 Hits
  • Search Condition : Filter (MeSH = Stomach Neoplasms / drug therapy)
Species Resource Title
DNA material pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
Human and Animal Cells MKN7 , MKN45(RCB1001) Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Human and Animal Cells HeLa Synthesis, photophysical properties, and photodynamic activity of positional isomers of TFPP-glucose conjugates.
Human and Animal Cells GCIY(RCB0555) , Kato III(RCB2088) , MKN74(RCB1002) , NUGC-4(RCB1939) Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
Human and Animal Cells MKN28(RCB1000) Antitumor Activity of Fucus vesiculosus-Derived Phlorotannins through Activation of Apoptotic Signals in Gastric and Colorectal Tumor Cell Lines.
Human and Animal Cells Kato III(RCB2088) , MKN74(RCB1002) , NUGC-4(RCB1939) , GSS(RCB2277) , GCIY(RCB0555) , MKN45(RCB1001) A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines.
Human and Animal Cells RAW 264(RCB0535) , L929 Structure-activity relationships of α-, β(1)-, γ-, and δ-tomatine and tomatidine against human breast (MDA-MB-231), gastric (KATO-III), and prostate (PC3) cancer cells.
Human and Animal Cells NUGC-4(RCB1939) MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53.
Human and Animal Cells Kato III(RCB2088) , MKN45(RCB1001) Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance.
Human and Animal Cells MKN45(RCB1001) Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.
DNA material CSII-CMV-RfA (RDB04386) SAA1 is upregulated in gastric cancer-associated fibroblasts possibly by its enhancer activation.
Human and Animal Cells HGC-27(RCB0500) SNAIL regulates gastric carcinogenesis through CCN3 and NEFL.
Human and Animal Cells MKN74(RCB1002) , MKN7(RCB0999) , MKN45(RCB1001) Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.
Human and Animal Cells MKN45(RCB1001) An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells.
Human and Animal Cells MKN7(RCB0999) , MKN45(RCB1001) , MKN74(RCB1002) , Kato III(RCB2088) Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Human and Animal Cells MKN1(RCB1003) , MKN7(RCB0999) Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
Human and Animal Cells NUGC-4(RCB1939) , MKN74(RCB1002) Downregulation of ARID1A in gastric cancer cells: a putative protective molecular mechanism against the Harakiri-mediated apoptosis pathway.
Human and Animal Cells MKN1(RCB1003) , MKN74(RCB1002) , GCIY(RCB0555) Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
Human and Animal Cells MKN45(RCB1001) Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells.
Human and Animal Cells MKN7(RCB0999) , MKN45(RCB1001) , MKN1(RCB1003) Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.